Official internet pharmacy in Sydney where you can buy Female Viagra online. Para compra levitra puede ser visto como un desafío. Aumenta Smomenta, y todos los que se poco a poco abrumado, como es lógico, cada vez más hombres están diagnosticados con disfunción eréctil.

Safety data sheet

Material Safety Data Sheet
1. PRODUCT AND COMPANY IDENTIFICATION
3050 Spruce Street SAINT LOUIS MO 63103 USA 2. COMPOSITION/INFORMATION ON INGREDIENTS
Ethionamide
536-33-4
3. HAZARDS IDENTIFICATION
Emergency Overview
OSHA Hazards
Target Organ Effect, Harmful by ingestion., Teratogen
Target Organs
HMIS Classification
Health Hazard:
Chronic Health Hazard:
Flammability:
Physical hazards:
NFPA Rating
Health Hazard:
Reactivity Hazard:
Potential Health Effects
Inhalation
May be harmful if inhaled. May cause respiratory tract irritation. May be harmful if absorbed through skin. May cause skin irritation. Ingestion
4. FIRST AID MEASURES
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.Move out of dangerous area.
If inhaled
If breathed in, move person into fresh air. If not breathing give artificial respiration Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Consult a physician.
In case of eye contact
Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
5. FIRE-FIGHTING MEASURES
Flammable properties
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special protective equipment for fire-fighters
Wear self contained breathing apparatus for fire fighting if necessary.
6. ACCIDENTAL RELEASE MEASURES
Personal precautions
Use personal protective equipment. Avoid dust formation. Avoid breathing dust. Ensure adequate ventilation.
Environmental precautions
Do not let product enter drains.
Methods for cleaning up
Pick up and arrange disposal without creating dust. Keep in suitable, closed containers for disposal.
7. HANDLING AND STORAGE
Handling
Avoid formation of dust and aerosols.
Provide appropriate exhaust ventilation at places where dust is formed. Normal measures for preventive fire
protection.
Storage
Keep container tightly closed in a dry and well-ventilated place.
Recommended storage temperature: 2 - 8 °C
8. EXPOSURE CONTROLS/PERSONAL PROTECTION
Contains no substances with occupational exposure limit values. Personal protective equipment
Respiratory protection
Where risk assessment shows air-purifying respirators are appropriate use a dust mask type N95 (US) or type P1
(EN 143) respirator. Use respirators and components tested and approved under appropriate government
standards such as NIOSH (US) or CEN (EU).
Hand protection
Handle with gloves.
Eye protection
Safety glasses with side-shields conforming to EN166
Skin and body protection
Choose body protection according to the amount and concentration of the dangerous substance at the work
place.
Hygiene measures
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and at the end
of workday.
9. PHYSICAL AND CHEMICAL PROPERTIES
Appearance
Safety data
10. STABILITY AND REACTIVITY
Storage stability
Stable under recommended storage conditions.
Materials to avoid
Strong oxidizing agents
Hazardous decomposition products
Hazardous decomposition products formed under fire conditions. - Carbon oxides, nitrogen oxides (NOx), Sulphur
oxides
11. TOXICOLOGICAL INFORMATION
Acute toxicity
Irritation and corrosion
Sensitisation
Chronic exposure
This product is or contains a component that is not classifiable as to its carcinogenicity based on its IARC, ACGIH, NTP, or EPA classification. 3 - Group 3: Not classifiable as to its carcinogenicity to humans (Ethionamide) No component of this product present at levels greater than or equal to 0.1% is identified as a carcinogen or potential carcinogen by ACGIH. No component of this product present at levels greater than or equal to 0.1% is identified as a known or anticipated carcinogen by NTP. No component of this product present at levels greater than or equal to 0.1% is identified as a carcinogen or potential carcinogen by OSHA. Laboratory experiments have shown teratogenic effects. Signs and Symptoms of Exposure
Gastrointestinal disturbance, Dermatitis, Liver injury may occur., Convulsions Potential Health Effects
Inhalation
May be harmful if inhaled. May cause respiratory tract irritation. May be harmful if absorbed through skin. May cause skin irritation. Ingestion
Target Organs
Additional Information
RTECS: NS0350000
12. ECOLOGICAL INFORMATION
Elimination information (persistence and degradability)
Ecotoxicity effects
Further information on ecology
13. DISPOSAL CONSIDERATIONS
Product
Observe all federal, state, and local environmental regulations. Contact a licensed professional waste disposal
service to dispose of this material. Dissolve or mix the material with a combustible solvent and burn in a chemical
incinerator equipped with an afterburner and scrubber.
Contaminated packaging
Dispose of as unused product.
14. TRANSPORT INFORMATION
DOT (US)
Not dangerous goods
IMDG
Not dangerous goods
IATA
Not dangerous goods
15. REGULATORY INFORMATION
OSHA Hazards
Target Organ Effect, Harmful by ingestion., Teratogen
DSL Status
This product contains the following components that are not on the Canadian DSL nor NDSL lists.
SARA 302 Components
SARA 302: No chemicals in this material are subject to the reporting requirements of SARA Title III, Section 302.
SARA 313 Components
SARA 313: This material does not contain any chemical components with known CAS numbers that exceed the
threshold (De Minimis) reporting levels established by SARA Title III, Section 313.
SARA 311/312 Hazards
Acute Health Hazard, Chronic Health Hazard
Massachusetts Right To Know Components
No components are subject to the Massachusetts Right to Know Act.
Pennsylvania Right To Know Components
New Jersey Right To Know Components
California Prop. 65 Components
WARNING! This product contains a chemical known in the State of California to cause birth defects or other reproductive harm. 16. OTHER INFORMATION
Further information
Copyright 2009 Sigma-Aldrich Co. License granted to make unlimited paper copies for internal use only.
The above information is believed to be correct but does not purport to be all inclusive and shall be used only as a
guide. The information in this document is based on the present state of our knowledge and is applicable to the
product with regard to appropriate safety precautions. It does not represent any guarantee of the properties of the
product. Sigma-Aldrich Co., shall not be held liable for any damage resulting from handling or from contact with
the above product. See reverse side of invoice or packing slip for additional terms and conditions of sale.

Source: http://www.elac.edu/departments/chemistry/chemistrydocuments/docs/E/ethionamide.pdf

Arzneimittelrückstände und hormonell wirksame substanzen i-205

Arzneimittelrückstände und hormonell wirksame Substanzen in Gewässern Arzneimittelrückstände in aquatischen Ökosystemen Nach dem derzeitigen Wissensstand sind Arzneistoffe aus der Humanmedizin wie Lipidsenker, Analgetika, ß-Blocker und Antiepileptika in Oberflächengewässern weit verbreitete Kontaminanten. Eine umfassende Risikoabschätzung über mögliche Auswirkungen von A

Pan_2302 100.106

Review articleDuchenne muscular dystrophy: an old anesthesiaproblem revisitedJASON H AYES M D F RC P C†, F R A N C I S V E Y C K E M A N S M D*A N D B R U N O B I S S O N N E T T E MD FRCPC††The Hospital for Sick Children, Toronto, ON, Canada and*Service d’Anesthe´siologie, Clinique universitaires St Luc, Brussels, BelgiumSummaryPatients with Duchenne and Becker muscular dystrophy suffe

Copyright © 2010-2014 PDF pharmacy articles